Halozyme Therapeutics Inc (HALO)

[friendofthedevil]

Yes. You know there will be some subjects who got a dose or two of PEG and then no more. When 202 was interrupted, there were patients in the middle of their chemo regimen. The Abraxane and Gemcitabine would have been continued even if the PEG could not. I would think there wasn't very many, then, who received later PEG dosing since most would have finished out the standard chemo.

Last summer, when I read what you quoted here, I wondered how many partial PEG subjects would have a donut hole with respect to PEG. I'll have to go back and count weeks, but there couldn't be many.

What could be interesting to see is if there is enough data to suggest the partial PEGs did better than full PEG. Doubt there is.